• Prestained Protein Marker: Triple-Color 10–250 kDa

  2026-08-27

  The APExBIO Prestained Protein Marker provides visible size references for SDS-PAGE, Western blot protein size verification, and transfer monitoring across 10–250 kDa. It is intended for denaturing electrophoresis and membrane workflows, including Phosbind and fluorescent imaging, but should not be treated as a universal native-PAGE standard or a quantitative protein assay calibrator.

• Standardized Whole-Blood Immunometabolism Protocol

  2026-08-27

  Zhao and colleagues introduce a standardized fresh whole-blood stimulation platform for testing how metabolic interventions reshape stimulus-dependent cytokine responses. By combining defined immune challenges with pathway-directed metabolic inhibition, the protocol offers a practical bridge between immunometabolism experiments and cohort-scale functional studies.

• Ruxolitinib in Anaplastic Thyroid Cancer

  2026-08-26

  The reference study identifies a mechanistic connection between JAK1/2–STAT3 activity, DRP1-dependent mitochondrial fission, and coordinated apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma. Its findings position Ruxolitinib phosphate, also known as INCB018424, as a preclinical tool for testing how JAK/STAT signaling pathway modulation can reshape mitochondrial dynamics and tumor-cell death.

• Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance

  2026-08-26

  The reference study developed a tumor-microenvironment-responsive nanoparticle platform for systemic PTEN mRNA delivery in trastuzumab-resistant breast cancer. Its findings support pathway reactivation through PTEN expression and show how environment-sensitive nanoparticle design can complement antibody therapy, while also highlighting the translational challenges of mRNA delivery.

• MEK1/2, c-Myc:MAX, and TERT in Human Stem Cells

  2026-08-25

  A 2024 bioRxiv study identifies a chromatin-based mechanism in which MEK1/2–ERK signaling and c-Myc:MAX cooperate to maintain TERT transcription in human pluripotent stem cells. The findings connect kinase activity and c-Myc function to protection of the TERT promoter from PRC2-associated repression, providing a mechanistic framework for studying telomerase regulation in normal stem cells.

• STL001, FOXM1 Suppression, and Cancer Sensitization

  2026-08-25

  The 2024 Cell Death Discovery study identifies STL001 as a more active FOXM1 inhibitor that can resensitize solid-cancer models to several conventional therapies. Its genetic and transcriptomic analyses support FOXM1 suppression as the basis of sensitization and highlight steroid/cholesterol biosynthesis and protein secretion as additional FOXM1-associated programs.

• PEGylated PLGA Microspheres for Extended Release

  2026-08-24

  Myers and Comolli optimized PEGylated PLGA microspheres carrying hydrocortisone 17-butyrate and used biphasic release modeling to distinguish surface desorption from diffusion-controlled delivery. PEGylation reduced the initial burst and supported sustained release over three weeks, providing a materials-based strategy for improving intra-articular corticosteroid exposure.

• Polygodial for TRPA1 Channel Research

  2026-08-24

  Use Polygodial as a practical TRPA1 channel activator for connecting rapid calcium influx with NFAT-dependent epithelial signaling and sensory-neuron responses. This workflow combines real-time ion-channel measurements, pathway controls, and cytokine endpoints to distinguish channel engagement from downstream inflammatory effects.

• Chlorpromazine HCl: From Receptor Probe to HDT

  2026-08-23

  Chlorpromazine HCl is a dopamine receptor antagonist with value beyond conventional neuropharmacology. This article develops a causal assay framework connecting receptor pharmacology, synaptic phenotypes, and emerging host-directed antibacterial research while distinguishing established evidence from testable hypotheses.

• Puromycin aminonucleoside: Podocyte Injury Workflows

  2026-08-22

  Build reproducible podocyte injury and proteinuria workflows with Puromycin aminonucleoside, from pH-aware cell assays to carefully controlled animal studies. The guide also shows how an independent epigenetic resistance study can inspire stronger, isoform-resolved readouts without overstating the renal model’s scope.

• Bestatin and Angiotensin Signaling in Rat Brain

  2026-08-22

  The 1987 Brain Research study used iontophoretic electrophysiology and complementary aminopeptidase inhibitors to test whether angiotensin II must be converted to angiotensin III before activating neurons. Its results support a precursor-to-active-peptide model while also showing why inhibitor effects must be interpreted alongside peptide degradation and receptor antagonism.

• EDC.HCl: Practical Coupling Workflow

  2026-08-21

  EDC.HCl is a water-soluble carbodiimide coupling reagent for activating carboxyl groups before amide bond formation with primary amines in in vitro peptide, bioconjugation, nucleotide, esterification, and lactonization workflows. It should be handled as a research reagent only; no in vivo or clinical data are available, and long-term storage of its solutions is not recommended.

• EZ Cap™ Human PTEN mRNA: Assay Design Guide

  2026-08-20

  EZ Cap™ Human PTEN mRNA (ψUTP) enables controlled restoration of PTEN expression in mammalian cancer research models. This guide focuses on delivery-aware assay design, mechanistic controls, and how to translate nanoparticle evidence into rigorous in vitro and in vivo experiments.

• Diminazene Aceturate: From Parasites to ACE2

  2026-08-20

  Diminazene Aceturate is best understood as a cross-domain research probe: a trypanocidal agent for parasitic infection research and a pharmacological tool for investigating ACE2–MasR–Sirt1 signaling and mitochondrial biogenesis in sepsis-related cardiac injury.

• Angiotensin Peptides and SARS-CoV-2 Receptor Binding

  2026-08-19

  The reference study identifies a structure-dependent role for naturally occurring angiotensin fragments in enhancing SARS-CoV-2 spike protein binding to host receptors, particularly AXL. Its antibody-based binding experiments connect renin-angiotensin system biology with viral-entry research while also showing why peptide truncation and residue modification must be considered when interpreting receptor interactions.

8034 records 1/536 page Next 12345 下5页 Last page